Dudediligence.

SCYNEXIS, Inc

SCYXNASDAQ · Pharmaceutical Preparations
Write an idea

Filings

Newest first

The annual , the quarterly and the filed between them when something material happens.

  1. Sep 288-KMaterial agreement and Regulation FD disclosure1.017.019.01
  2. Sep 228-KOfficer or director change and Regulation FD disclosure5.027.019.01
  3. Sep 108-KOfficer or director change and other events5.028.01
  4. Aug 1213GPassive stake of 5% or more (13G), filed by Adage Capital Management
  5. Aug 1010-QQuarterly report
  6. Jun 268-KBylaws or fiscal year changed and other events5.035.078.019.01
  7. May 298-KBylaws or fiscal year changed5.039.01
  8. May 228-KOther events and shareholder vote5.078.01
  9. May 1110-QQuarterly report
  10. May 8424B3Prospectus for an offering
  11. May 1S-3Shelf registration
  12. Apr 208-KOfficer or director change5.02
  13. Mar 318-KRegulation FD disclosure7.019.01
  14. Mar 318-KMaterial agreement and unregistered sale of shares1.013.027.018.019.01
  15. Mar 318-KMaterial agreement and acquisition or sale of assets completed1.012.017.019.01
  16. Mar 410-KAnnual report
  17. Nov 5, 202510-QQuarterly report
  18. Oct 15, 20258-KMaterial agreement1.01
  19. Aug 13, 202510-QQuarterly report
  20. Jul 1, 20258-KShareholder vote5.07
  21. Jun 26, 20258-KListing notice or transfer3.01
  22. May 15, 202510-QQuarterly report
  23. Mar 12, 202510-KAnnual report
  24. Nov 6, 20248-KOther events8.019.01
  25. Nov 6, 2024424B5Prospectus for an offering
  26. Nov 6, 202410-QQuarterly report